Prof. Dulce Brito was a prominent figure at the round table promoted by Vifor Pharma, where she addressed the role of neurohormonal antagonists in the current therapy of heart failure, the need to optimize therapy according to the guidelines, and how new potassium scavengers can contribute to this optimization.
Access here to access the interview.